Medidata
Medidata Solutions, Inc., headquartered in the United States, is a leading player in the life sciences industry, specialising in cloud-based solutions for clinical trials. Founded in 1999, the company has achieved significant milestones, including the development of innovative technologies that streamline the drug development process. With a strong presence in North America, Europe, and Asia, Medidata offers a comprehensive suite of products and services, including data management, analytics, and patient engagement tools. Their unique platform integrates advanced analytics and artificial intelligence, enabling biopharmaceutical companies to enhance decision-making and improve trial outcomes. Recognised for its market leadership, Medidata has been instrumental in transforming clinical research, supporting over 25,000 trials and 5 million patients globally. The company’s commitment to innovation and excellence positions it as a trusted partner in the evolving landscape of clinical development.
DitchCarbon Score
How does Medidata's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medidata's score of 37 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medidata's reported carbon emissions
In 2019, Medidata reported total carbon emissions of approximately 15,014,000 kg CO2e from Scope 3, which includes significant contributions from business travel (about 15,014,000 kg CO2e) and employee commuting (approximately 9,747,000 kg CO2e). The company also recorded Scope 1 emissions of about 242,160 kg CO2e and Scope 2 emissions of approximately 1,834,440 kg CO2e. Comparatively, in 2018, Medidata's emissions were approximately 12,997,000 kg CO2e from Scope 3, with business travel accounting for about 12,997,000 kg CO2e and Scope 1 emissions at around 462,420 kg CO2e, while Scope 2 emissions were about 1,672,000 kg CO2e. In 2017, the company reported no Scope 1 emissions, with Scope 2 emissions of approximately 1,831,000 kg CO2e and Scope 3 emissions totalling about 6,330,040 kg CO2e. Despite the detailed emissions reporting, Medidata has not publicly committed to specific reduction targets or initiatives, such as those aligned with the Science Based Targets initiative (SBTi). The absence of documented reduction targets suggests a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | |
|---|---|---|---|
| Scope 1 | - | 000,000 | 000,000 |
| Scope 2 | 1,831,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 6,330,040 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medidata is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
